Home Newsfeeds Piper Sandler Downgrades Broadmark Realty Capital to Underweight

Piper Sandler Downgrades Broadmark Realty Capital to Underweight

Piper Sandler analyst Crispin Love downgrades Broadmark Realty Capital (NYSE:BRMK) from Neutral to Underweight.

byBenzinga Newsdesk

August 9, 2022

1 minute read

Piper Sandler analyst Crispin Love downgrades Broadmark Realty Capital (NYSE:BRMK) from Neutral to Underweight.

HC Wainwright & Co. Maintains Buy on Novavax, Lowers Price Target to $110

By Benzinga Newsdesk

January 2, 7:30 AM

HC Wainwright & Co. analyst Vernon Bernardino maintains Novavax (NASDAQ:NVAX) with a Buy and lowers the price target from $207 to $110.

NVAX

TD Cowen Maintains Outperform on MasTec, Raises Price Target to $125

By Benzinga Newsdesk

March 6, 9:29 AM

TD Cowen analyst Marc Bianchi maintains MasTec (NYSE:MTZ) with a Outperform and raises the price target from $115 to $125.

MTZ

Tilray’s New Cannabis Strains By Redecan: Here’s Where To Find These Innovative Products

By Jelena Martinovic

September 7, 9:43 AM

Tilray Brands, Inc. (NASDAQ: TLRY) (TSX: TLRY) is expanding its market-leading product portfolio by launching new flower genetics by the cannabis lifestyle brand Redecan.

TLRY

Morgan Stanley Maintains Equal-Weight on Tricon Residential, Lowers Price Target to $11.75

By Benzinga Newsdesk

July 15, 12:55 PM

Morgan Stanley analyst Richard Hill maintains Tricon Residential (NYSE:TCN) with a Equal-Weight and lowers the price target from $13.5 to $11.75.

TCN

Piper Sandler Downgrades Broadmark Realty Capital to Underweight

Related Posts

HC Wainwright & Co. Maintains Buy on Novavax, Lowers Price Target to $110

TD Cowen Maintains Outperform on MasTec, Raises Price Target to $125

Tilray’s New Cannabis Strains By Redecan: Here’s Where To Find These Innovative Products

Morgan Stanley Maintains Equal-Weight on Tricon Residential, Lowers Price Target to $11.75